Prescriptions convey a sense of legitimacy. A doctor's name is on the label. The drugs came from a licensed pharmacy. There was a diagnosis, a legit reason for them. Someone with a medical degree looked at the situation and decided this was appropriate.
These things shape how people think about medication, how they talk about it, and crucially, how long they wait before recognizing that something has gone awry.
Your Brain on Prescription Drugs
Benzodiazepines and prescription opioids work on the same fundamental architecture as every other addictive substance. Benzos bind to GABA receptors and suppress the central nervous system. Opioids bind to mu-opioid receptors and trigger dopamine release in the mesolimbic reward pathway. Both produce tolerance. Both produce physical dependence. Both produce withdrawal symptoms when discontinued.
The fact that a physician authorized the first dose changes the legal and social context of use significantly. But it doesn’t change the neurobiology.
What changes neurobiology is time and dose. And women are more likely to be on these medications longer than men, at escalating doses, for conditions that the medications are quietly making worse.
Why Women Specifically
Research on opioid use disorder in women found that compared to men, women are more likely to be prescribed opioid medications, given higher doses, and to use opioids for longer periods of time. The same research found that craving for opioids was significantly higher among women in treatment compared to men, even after controlling for severity of use.
The reasons are partly biological, overlapping with the telescoping effect documented in a previous blog. They are also structural. Women are more likely to present to primary care with anxiety, chronic pain, and sleep disorders, which are the three most common indications for benzodiazepine prescriptions. Women are more likely to receive prescriptions for those presentations. And the medical culture around prescribing to women for these conditions has historically been less conservative than it should have been.
The result is that a significant portion of women who end up in treatment for prescription drug dependence got there through entirely legitimate channels: an appointment, a diagnosis, a prescription, a refill, another refill.
Prescription Benzos & Opioids
The combination of benzodiazepines and opioids deserves particular attention because it is common and because its consequences are multiplicative rather than additive.
A large-scale retrospective cohort study examined over 626,000 patients with anxiety disorders, two-thirds of whom were women. Patients prescribed benzodiazepines were found to have a 2.20 times higher hazard ratio for developing a substance use disorder compared to matched controls who were not prescribed benzodiazepines. For opioid use disorder specifically, that ratio rose to 3.38. The study concluded plainly that clinicians should be cautious while prescribing benzodiazepines and inform patients about the associated risks.
The Cycle That Traps People
Anxiety and chronic pain are the primary reasons women receive these prescriptions. They are also the primary symptoms of withdrawal from the medications used to treat them.
Long-term benzodiazepine use sensitizes the brain's anxiety circuits. The medication that was prescribed to quiet anxiety gradually makes the underlying anxiety system more reactive. When the dose is reduced, anxiety spikes, sometimes to levels far beyond anything the person experienced before the prescription began. The solution that appears logical, the one that works immediately, is to take more of what's causing the problem.
Why Stopping Alone Is Not the Answer
Benzodiazepine withdrawal is one of the most medically dangerous withdrawal processes that exists. Unlike opioid withdrawal, which is agonizing but rarely fatal, benzo withdrawal can produce seizures, psychosis, and cardiovascular instability when managed incorrectly. This is not a minor risk. It is a documented medical reality that every person on long-term benzodiazepines should understand before they consider stopping without professional supervision.
The reason so many women attempt it alone is the same reason they delayed recognizing the problem in the first place: the prescription made it feel manageable. Like something they could handle themselves. Like something that didn't require the kind of help people get when they have a "real" problem.
Treatment for Prescription Drug Dependence
Treating dependence on prescribed medications requires the same clinical rigor as treating any other substance use disorder, and for benzos it requires medical supervision of the tapering process before any other therapeutic work can happen.
Owl's Nest Recovery provides individualized addiction treatment plans that address the specific clinical picture each person brings in, including dependence on benzodiazepines and prescription opioids. For women whose prescription drug dependence developed alongside anxiety, depression, or trauma, dual diagnosis treatment addresses the underlying conditions that the prescription was managing, often inadequately, before the dependence took hold. PHP and IOP provide the level of clinical structure that the step-down from prescription dependence requires.
The label on the bottle did not cause this. The brain's adaptation to what was in the bottle did. That's a medical reality, and it has a clinical response.
Comments